BRD4 binds to active cranial neural crest enhancers to regulate RUNX2 activity during osteoblast differentiation
Development · 2024
DOI: 10.1242/dev.202110 ↗At a glance
Journal article in Development, 2024. Written by Rachel E Musa and 7 co-authors. Institution: Department of Genetics, University of North Carolina, Chapel Hill, NC 27599-7264, USA. Major MEDLINE topics: De Lange Syndrome, Transcription Factors. Cited 12 times so far (Crossref); 101 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIAID NIH HHS, NIDCR NIH HHS, National Institute of Dental and Craniofacial Research.
Abstract (original language)
Cornelia de Lange syndrome (CdLS) is a congenital disorder featuring facial dysmorphism, postnatal growth deficits, cognitive disability and upper limb abnormalities. CdLS is genetically heterogeneous, with cases arising from mutation of BRD4, a bromodomain protein that binds and reads acetylated histones. In this study, we have modeled CdLS facial pathology through mouse neural crest cell (NCC)-specific mutation of BRD4 to characterize cellular and molecular function in craniofacial development. Mice with BRD4 NCC loss of function died at birth with severe facial hypoplasia, cleft palate, mid-facial clefting and exencephaly. Following migration, BRD4 mutant NCCs initiated RUNX2 expression for differentiation to osteoblast lineages but failed to induce downstream RUNX2 targets required for lineage commitment. BRD4 bound to active enhancers to regulate expression of osteogenic transcription factors and extracellular matrix components integral for bone formation. RUNX2 physically interacts with a C-terminal domain in the long isoform of BRD4 and can co-occupy osteogenic enhancers. This BRD4 association is required for RUNX2 recruitment and appropriate osteoblast differentiation. We conclude that BRD4 controls facial bone development through osteoblast enhancer regulation of the RUNX2 transcriptional program.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Genetics, University of North Carolina, Chapel Hill, NC 27599-7264, USA.
- Laboratory of Endocrinology and Receptor Biology, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
ORCID profiles: Kai Ge, Karl B Shpargel
Funding
- NIAID NIH HHS
- NIDCR NIH HHS
- National Institute of Dental and Craniofacial Research
- National Institute of Allergy and Infectious Diseases
- US Army Medical Research Acquisition Activity
- University of North Carolina at Chapel Hill
Cite
APA
Musa, R. E., Lester, K. L., Quickstad, G., Vardabasso, S., Shumate, T. V., Salcido, R. T., Ge, K., & Shpargel, K. B. (2024). BRD4 binds to active cranial neural crest enhancers to regulate RUNX2 activity during osteoblast differentiation. Development. https://doi.org/10.1242/dev.202110
Vancouver
Musa RE, Lester KL, Quickstad G, Vardabasso S, Shumate TV, Salcido RT, et al. BRD4 binds to active cranial neural crest enhancers to regulate RUNX2 activity during osteoblast differentiation. Development. 2024. doi:10.1242/dev.202110
BibTeX
@article{Musa2024,
author = {Musa, Rachel E and Lester, Kaitlyn L and Quickstad, Gabrielle and Vardabasso, Sara and Shumate, Trevor V and Salcido, Ryan T and Ge, Kai and Shpargel, Karl B},
title = {BRD4 binds to active cranial neural crest enhancers to regulate RUNX2 activity during osteoblast differentiation},
journal = {Development},
year = {2024},
doi = {10.1242/dev.202110}
}
EUVIMED